NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Buy
55
HTEC Quote, Financials, Valuation and Earnings
Last price:
$28.92
Seasonality move
:
-6.6%
Day range:
$28.25 - $29.22
52-week range:
$25.69 - $30.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
23.3K
Avg. volume:
11.8K
1-year change:
7.24%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.03 | -- | -- | -- | $0.00 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.24 | -- | -- | -- | $0.10 | 0.75% | -- |
|
CANC
Tema Oncology ETF
|
$24.45 | -- | -- | -- | $0.96 | 2.98% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$29.15 | -- | -- | -- | $0.47 | 0.49% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 1.201 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.605 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
ROBO Global Healthcare Technology & Innovation ETF vs. Competitors
-
Which has Higher Returns HTEC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Global X Aging Population ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HTEC or AGNG More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.75% to investors and pays a quarterly dividend of $0.10 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or AGNG?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HTEC or CANC?
Tema Oncology ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About HTEC or CANC?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Tema Oncology ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is HTEC or CANC More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HTEC or CANC?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tema Oncology ETF offers a yield of 2.98% to investors and pays a quarterly dividend of $0.96 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or CANC?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns HTEC or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to ROBO Global Healthcare Technology & Innovation ETF's net margin of --. ROBO Global Healthcare Technology & Innovation ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About HTEC or HRTS?
ROBO Global Healthcare Technology & Innovation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ROBO Global Healthcare Technology & Innovation ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe ROBO Global Healthcare Technology & Innovation ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is HTEC or HRTS More Risky?
ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, which suggesting that the stock is 6.985% more volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HTEC or HRTS?
ROBO Global Healthcare Technology & Innovation ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. ROBO Global Healthcare Technology & Innovation ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HTEC or HRTS?
ROBO Global Healthcare Technology & Innovation ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. ROBO Global Healthcare Technology & Innovation ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, ROBO Global Healthcare Technology & Innovation ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ROBO Global Healthcare Technology & Innovation ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 1.96% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.6% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.43% over the past day.
